摘要
The intestinal tract, with high expression of angiotensin-converting enzyme 2 (ACE2), is a major site of extrapulmonary infection in COVID-19. During pulmonary infection, the virus enters the bloodstream forming viremia, which infects and damages extrapulmonary organs. Uncontrolled viral infection induces cytokine storm and promotes a hypercoagulable state, leading to systemic microthrombi. Both viral infection and microthrombi can damage the gut-blood barrier, resulting in malabsorption, malnutrition, and intestinal flora entering the blood, ultimately increasing disease severity and mortality. Early prophylactic antithrombotic therapy can prevent these damages, thereby reducing mortality. In this review, we discuss the effects of SARS-CoV-2 infection and intestinal thrombosis on intestinal injury and disease severity, as well as corresponding treatment strategies.
学科与关键词
- SARS-CoV-2 and gastrointestinal diseasesSha, Ailong*; Liu, Yi; Zhao, XuewenFrontiers in Microbiology, 2023, 14: 1177741.被引 2
- Remarkable gastrointestinal and liver manifestations of COVID-19: A clinical and radiologic overviewFang, Li-Guang; Zhou, Quan*World Journal of Clinical Cases, 2021, 9(19): 4969-4979.被引 3
- Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potentialXiang, Hui*; Liu, Qi-PingWORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28(47): 6689-6701.被引 5
